D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 111 Citations 56,133 370 World Ranking 2290 National Ranking 95

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

Robert S. Kerbel spends much of his time researching Cancer research, Angiogenesis, Immunology, Internal medicine and Chemotherapy. Robert S. Kerbel combines subjects such as Cell culture, Cell growth, Tyrosine kinase, Tumor progression and Kinase with his study of Cancer research. Robert S. Kerbel interconnects Vascular endothelial growth factor A, Vascular endothelial growth factor, Endothelial stem cell and Receptor tyrosine kinase in the investigation of issues within Angiogenesis.

Robert S. Kerbel has researched Immunology in several fields, including In vitro, Bioinformatics, Progenitor cell, Stem cell and Phenotype. His Internal medicine study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Endocrinology and Oncology. His Chemotherapy research integrates issues from Cancer and Pharmacology.

His most cited work include:

  • Angiogenesis as a therapeutic target (2164 citations)
  • Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis (1471 citations)
  • Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis (1471 citations)

What are the main themes of his work throughout his whole career to date?

Robert S. Kerbel mostly deals with Cancer research, Internal medicine, Cancer, Angiogenesis and Immunology. His research integrates issues of Cell culture, Metastasis, Chemotherapy and Tumor progression in his study of Cancer research. His work deals with themes such as Tumor microenvironment and Regimen, which intersect with Chemotherapy.

His Internal medicine study incorporates themes from Endocrinology and Oncology. His Angiogenesis research includes themes of Endothelial stem cell, Vascular endothelial growth factor A, Vascular endothelial growth factor and Blood vessel. His Immunology research includes elements of Phenotype, Drug resistance and Progenitor cell.

He most often published in these fields:

  • Cancer research (61.26%)
  • Internal medicine (33.98%)
  • Cancer (29.00%)

What were the highlights of his more recent work (between 2012-2020)?

  • Internal medicine (33.98%)
  • Cancer (29.00%)
  • Cancer research (61.26%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Cancer, Cancer research, Oncology and Breast cancer. He usually deals with Internal medicine and limits it to topics linked to Melanoma and Disseminated disease and Brain metastasis. His study looks at the relationship between Cancer and topics such as Pharmacology, which overlap with Camptothecin, Toxicity, Drug resistance, Intensive care medicine and Low-dose chemotherapy.

His Cancer research research is mostly focused on the topic Angiogenesis. His work carried out in the field of Oncology brings together such families of science as Clinical trial, Bevacizumab, Chemotherapy, Adjuvant therapy and Metronomic Chemotherapy. His work deals with themes such as Regimen, Colorectal cancer, Primary tumor and Immunology, which intersect with Breast cancer.

Between 2012 and 2020, his most popular works were:

  • Antiangiogenic therapy in oncology: current status and future directions. (393 citations)
  • Consensus guidelines for the use and interpretation of angiogenesis assays (194 citations)
  • Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa. (145 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

The scientist’s investigation covers issues in Pharmacology, Cancer, Cancer research, Internal medicine and Oncology. His Pharmacology research includes themes of Bevacizumab, Chemotherapy, Metastatic breast cancer, Toxicity and Drug resistance. The study incorporates disciplines such as Disease progression and Pathology in addition to Cancer.

Robert S. Kerbel specializes in Cancer research, namely Neovascularization. His Oncology study integrates concerns from other disciplines, such as Colorectal cancer and Melanoma. His study in Metastasis is interdisciplinary in nature, drawing from both Blood vessel and Angiogenesis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Angiogenesis as a therapeutic target

Napoleone Ferrara;Robert S. Kerbel.
Nature (2005)

3034 Citations

Clinical translation of angiogenesis inhibitors.

Robert Kerbel;Judah Folkman.
Nature Reviews Cancer (2002)

1996 Citations

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

John M.L. Ebos;Christina R. Lee;William Cruz-Munoz;Georg A. Bjarnason.
Cancer Cell (2009)

1956 Citations

The anti-angiogenic basis of metronomic chemotherapy

Robert S. Kerbel;Barton A. Kamen.
Nature Reviews Cancer (2004)

1502 Citations

Tumor angiogenesis: past, present and the near future.

Robert S. Kerbel.
Carcinogenesis (2000)

1434 Citations

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Giannoula Klement;Sylvain Baruchel;Janusz Rak;Shan Man.
Journal of Clinical Investigation (2000)

1410 Citations

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

Alicia M. Viloria Petit;Janusz Rak;Mien Chie Hung;Patricia Rockwell.
American Journal of Pathology (1997)

1262 Citations

Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis

James W. Dennis;Suzanne Laferte;Carol Waghorne;Martin L. Breitman.
Science (1987)

1118 Citations

Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.

J. Rak;Y. Mitsuhashi;L. Bayko;J. Filmus.
Cancer Research (1995)

999 Citations

Establishment and Characterization of First Trimester Human Trophoblast Cells with Extended Lifespan

Charles H. Graham;Teresa S. Hawley;Robert C. Hawley;John R. MacDougall.
Experimental Cell Research (1993)

931 Citations

Best Scientists Citing Robert S. Kerbel

Rakesh K. Jain

Rakesh K. Jain

Harvard University

Publications: 95

Napoleone Ferrara

Napoleone Ferrara

University of California, San Diego

Publications: 85

adrian l harris

adrian l harris

University of Oxford

Publications: 80

Domenico Ribatti

Domenico Ribatti

University of Bari Aldo Moro

Publications: 80

Yihai Cao

Yihai Cao

Karolinska Institute

Publications: 74

Peter Carmeliet

Peter Carmeliet

KU Leuven

Publications: 69

Judah Folkman

Judah Folkman

Boston Children's Hospital

Publications: 62

Isaiah J. Fidler

Isaiah J. Fidler

The University of Texas MD Anderson Cancer Center

Publications: 61

Lee M. Ellis

Lee M. Ellis

The University of Texas MD Anderson Cancer Center

Publications: 60

Naoyuki Taniguchi

Naoyuki Taniguchi

Osaka University

Publications: 53

Peeyush K. Lala

Peeyush K. Lala

University of Western Ontario

Publications: 52

Gregg L. Semenza

Gregg L. Semenza

Johns Hopkins University School of Medicine

Publications: 51

Fortunato Ciardiello

Fortunato Ciardiello

University of Campania "Luigi Vanvitelli"

Publications: 50

James W. Dennis

James W. Dennis

Lunenfeld-Tanenbaum Research Institute

Publications: 50

Robert M. Hoffman

Robert M. Hoffman

AntiCancer (United States)

Publications: 49

Daniel J. Hicklin

Daniel J. Hicklin

MSD (United States)

Publications: 47

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.